This track will explore the latest discoveries in cancer biology, focusing on the molecular mechanisms underlying tumor development and progression. Researchers are invited to present their findings on genetic, epigenetic, and environmental factors influencing cancer pathogenesis.

This session will highlight novel therapeutic strategies and interventions in oncology, including targeted therapies and immunotherapy. Participants will discuss the efficacy and safety of emerging treatment modalities in various cancer types.

This track will delve into the role of precision medicine in tailoring cancer treatment to individual patient profiles. Presentations will focus on the integration of genomic data and biomarkers in clinical decision-making.

This session aims to discuss the translation of laboratory research into clinical applications in oncology. Researchers and clinicians will share insights on overcoming barriers to effective implementation of innovative therapies.

This track will emphasize the importance of patient-centered approaches in oncology care, including communication, shared decision-making, and psychosocial support. Presenters will explore strategies to enhance patient engagement and satisfaction.

This session will address the impact of health policy on cancer prevention, treatment, and survivorship. Experts will discuss current policies, challenges, and opportunities for improving access to quality oncology care.